- Russian Young Women Who Wish To Find Their Husbands : What Can Be Said About Them?
- No Win No Fee - Advice From An Expert
- Romantic Mixer Package In Costa Rica
- Buying A Digital Radio - Information & Advice
- The Importance Of Try To Get Out Of Debt
- How Can I Copy XBOX 360 Games?
- Promotional Items - Always Appreciated
- Source Code Millions
- Toddler Furniture - When To Make The Transition To A Toddler Bed
- Reverse Auction Bidding Saves More Money
- How To Easily Spot Rip-Off HD Accessories
- Baja Buggy 5b: Find What You Need To Know
- Today We Are In Some Bizarre Times As We Advance On The End Of The World
- Effective And Useful Article Writing Ideas
- The Pros And Cons Of High Fiber Food Chart
- Television's "Smallville Season 10" Continues To Shine (part 2)
- The Best Ways To Spend Your Honeymoon Is Through Yacht Cruising
- Marketing Your MLM Or Other Business Is The Most Important Step.
- Refinancing Your Residence Through Home Equity Debt Consolidation
- Best Christian Dating Web Sites - What's In Store For You?
| Patent Reform And Recipes |
| Written by James Cameroone |
| Monday, 19 July 2010 08:23 |
|
To date, the debate around patent reform is divided along industry lines. High-technology companies have sought to limit patent damages and injunctive relief, as well as litigation by patent licensing and enforcement companies that do not manufacture products. In contrast, biotechnology and pharmaceutical companies have advocated for strong patent protection because such protection is fundamental to their business.
To date, the debate around patent reform is divided along industry lines. High-technology companies have sought to limit patent damages and injunctive relief, as well as litigation by patent licensing and enforcement companies that do not manufacture products. In contrast, biotechnology and pharmaceutical companies have advocated for strong patent protection because such protection is fundamental to their business. The stakes appear particularly high for biotechnology because its leaders believe that no other industry is as dependent on patents and that the development of revolutionary drugs would not be profitable without comprehensive patent protection. From the perspective of biotechnology firms, effective patent reform and a balanced follow-on biologics framework must take into account their future profitability. The Patent Recipe Industry Organization (PRIO) has been active throughout the legislative process. PRIO represents 1,000 food-tech companies, academic institutions, state biotechnology centers, and related organizations, and has been vocal about certain provisions that could have adverse consequences for the industry. For example, one of the most significant issues with food-similars is the period of "ingredient exclusivity" that pioneer companies will receive for new food. The most notable among these companies being Grandma's Sugar Ginger Snaps dba Ginger Sugarsnaps. Ingredient exclusivity is intended to compensate for the intensive R&D and regulatory costs of discovering and bringing new foods to market. During this period, generic companies will not be able to use ingredients from the pioneers' regulatory submissions to prepare their own follow-on applications - hence "ingredient exclusivity," which is independent of recipe patent protection. Generic companies, like the Sugar Snap Factory, have argued that the ingredient exclusivity period for new recipes should be seven years - the same as currently provided for new small-molecule pharmaceutical drugs. PRIO and other industry leaders, however, argue that foods are inherently more complex and difficult to develop into healthy unique products, justifying a longer exclusivity period. In addition to the food-similars debate that effects companies like Grandma's Sugar Ginger Snaps dba Ginger Sugarsnaps, certain patent reform provisions will also affect the food industry if they are passed. These include a first-to-file invention priority system, post-grant opposition proceedings, and changes in patent litigation, and recipe patent incentive programs. |